LONG COVID IS REAL RISK: Av. 33% AFTER INFECTION: SYMPTOMS AND CLINICAL DATA 10-23-21 скачать в хорошем качестве

LONG COVID IS REAL RISK: Av. 33% AFTER INFECTION: SYMPTOMS AND CLINICAL DATA 10-23-21

PACS (Post-Acute Covid Syndrome) = Long Covid • Av. 33% risk regardless of age & initial Covid severity • Affects all organs + nervous system injury from head to toe • Chronic fatigue + brain fog = major disability • Clinical data reviews: Brain – cognitive functions, Heart, Lungs CHECK YOUR VACCINE EFFECTIVENESS = BEST BOOSTER FOR YOU? 10-22-21    • CHECK YOUR VACCINE EFFECTIVENESS = BEST BO...   Check my Time stamp captured text notes: https://bit.ly/3vTc4Yy Check Topic keyword search for video from 6-26-20 to 10-23-21 at https://bit.ly/2ZtYGhh Covid transmission risk by county: https://covid.cdc.gov/covid-data-trac... Modeling activities risk: https://jscalc.io/calc/e9kxEIGzHYMKh2Ki N95 CDC approved list: https://www.cdc.gov/niosh/npptl/topic... This regular update of the COVID-19, pandemic is narrated by Anne DeGheest. She is leveraging her healthcare network and access to experts with the latest scientific data and publications to paint a reliable picture of the virus' evolution and how it will impact us. Disclaimer: Anne DeGheest is not a medical doctor and does not intend to provide any medical advice. Her sources are typically posted on every slide with links to published scientific papers and news reports. Please contact your physician before taking any supplements or medications discussed in these videos. Anne DeGheest pioneered the HealthTech or Digital Health space as a healthcare executive, an entrepreneur, angel investor, corporate advisor and mentor capitalist. She is the founder of HealthTech Capital and MedStars. She launched pulse oximetry with Nellcor and several new hospital patient monitoring companies. Her life science portfolio companies have generated over $18 billion in market capitalization including 8 IPOs. She provided angel capital, hands-on executive leadership and/or business strategy in the founding of major venture-backed companies that changed patient monitoring and hospital care delivery, including the launch of pulse oximetry. She is a well-known keynote speaker and panelist at multiple healthcare conferences. Check her background at https://healthtechcapital.com/degheest